Skip to content
1587-Hijacking Exocytosis for Metabolic Reprogramming episode artwork

Sep 18, 2026 23 min

1587-Hijacking Exocytosis for Metabolic Reprogramming

from Paper Talk

The paper details the development of a dual-compartment lipid carrier system designed to overcome the immunosuppressive effects of lactate in solid tumors. By engineering natural killer (NK) cells to carry nicotinamide mononucleotide (NMN) and dichloroacetate (DCA), researchers successfully restored intracellular NAD+ levels and depleted extracellular lactate. This innovative approach "hijacks" the ER-Golgi secretory pathway, allowing for the precise, localized release of therapeutic payloads at the tumor site. Experimental results in osteosarcoma models and patient-derived xenografts demonstrate that this spatiotemporal metabolic reprogramming significantly enhances immune cell persistence and tumor suppression. Furthermore, the study suggests this exocytosis-co-option strategy is a versatile platform that can be adapted to improve the efficacy of T cell and macrophage therapies. Overall, the work establishes a new method for empowering cellular immunotherapies against metabolically hostile cancer environments without inducing systemic toxicity. References: Chen S, Shao Z, Zhou Y, et al. Dual compartment lipid carriers hijack exocytosis to empower natural killer cells against solid tumours[J]. Nature Communications, 2026. 前往小宇宙评论区与主播互动

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

1587-Hijacking Exocytosis for Metabolic Reprogramming

0:00 23:39

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Paper Talk?

This episode is 23 minutes long.

When was this Paper Talk episode published?

This episode was published on September 18, 2026.

Can I download this Paper Talk episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.